reviewCancerJun 2, 2008Closed access

A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma

University of Waterloo · Juravinski Cancer Centre · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

The use of adjuvant chemotherapy to treat adults with localized resectable soft-tissue sarcoma remains controversial. The objective of this systematic review was to update the 1997 meta-analysis of randomized controlled trials (RCTs) to reassess the efficacy of doxorubicin-based chemotherapy with respect to recurrence and survival.

Methods

A comprehensive literature search was performed to identify RCTs of adjuvant chemotherapy for adult patients diagnosed with localized resectable soft-tissue sarcoma. Two reviewers independently assessed eligibility and quality of the studies using a modified version of the Detsky Quality Scale. The outcome measures were local, distant, and overall recurrence and survival calculated through the fixed effect or random effect model.

Citation impact

976
total citations
FWCI
26.84
Percentile
100%
References
30
Citations per year

Authors

6

Topics & keywords

Keywords
  • Medicine
  • Soft tissue sarcoma
  • Ifosfamide
  • Chemotherapy
  • Sarcoma
  • Doxorubicin
  • Oncology
  • Randomized controlled trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.